Unilever sees investor backlash over $68B bid for GlaxoSmithKline consumer unit
Unilever sees investor backlash over $68B bid for GlaxoSmithKline consumer unit
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
Consumer goods giant Unilever cutting 1,500 management jobs
SeattlePI.com
LONDON (AP) — Unilever, which makes Vaseline skin care products and Ben & Jerry’s ice cream, says it's laying off 1,500 staff..
-
Unilever won't top $68B bid for GSK consumer healthcare unit
SeattlePI.com
-
Unilever rules out increasing £50bn bid for GSK unit after backlash
FT.com
-
GlaxoSmithKline drops on report that Unilever won't increase bid for consumer unit above GBP50B
SeekingAlpha
-
Unilever’s bid for consumer unit unlikely to generate upside for GlaxoSmithKline - BofA
SeekingAlpha